Showing results (1281-1290 of 1,339) with videos related to
Sort By:
Pageof 134
Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.Oncogene|April 2, 2020
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progressionDarshan S Chandrashekar, Balabhadrapatruni V S K Chakravarthi, Alyncia D Robinson, et al.The Journal of Clinical Investigation|March 1, 2022
SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signalingChuan Xu, Guoxiang Jin, Hong Wu, et al.Plos Medicine|March 4, 2021
Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey dataDavid Peiris, Arpita Ghosh, Jennifer Manne-Goehler, et al.Cancers|July 20, 2019
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional StudyShristi Bhattarai, Sergey Klimov, Karuna Mittal, et al.Pharmacological Research|March 31, 2016
Off-Target drug effects resulting in altered gene expression events with epigenetic and "Quasi-Epigenetic" originsStephen J Anderson, Kristina M Feye, Garrett R Schmidt-McCormack, et al.The Lancet. Diabetes & Endocrinology|October 12, 2016
Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countriesJennifer Manne-Goehler, Rifat Atun, Andrew Stokes, et al.Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.Bulletin of the World Health Organization|November 3, 2025
Use of traditional medicine for hypertension, diabetes and hypercholesterolaemia measured in 71 surveysMubarak Ayodeji Sulola, Abla M Sibai, Albertino Damasceno, et al.Journal of Medicinal Chemistry|March 6, 2009
Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamilyGretchen M Schroeder, Yongmi An, Zhen-Wei Cai, et al.Pageof 134